{"id":"W4403812934","doi":"10.1093/eurheartj/ehae666.3038","title":"Treatment of Post-COVID-19 POTS by inhibiting FcRn: a phase 2 randomized, placebo controlled, double-blind, proof of concept study with efgartigimod","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Placebo; Double blind; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Proof of concept; Internal medicine; Virology; Pharmacology; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003011488,0.002479603,0.003978066,0.0005464043,0.0006311745,0.001329749,0.001571756,0.003452124,0.006414789],"category_scores_gemma":[0.001645079,0.0008260596,0.002157552,0.0004426115,0.001401393,0.001702852,0.0003964214,0.003194759,0.0008859125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006185256,"about_ca_system_score_gemma":0.001716116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005342741,"about_ca_topic_score_gemma":0.001238184,"domain_scores_codex":[0.9992416,0.000314025,0.00006497786,0.0001343774,0.00006716783,0.0001779812],"domain_scores_gemma":[0.9991001,0.0001752634,0.0002130257,0.00008547254,0.0001163674,0.0003097587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9233691,0.03862627,0.0004446103,0.00169367,0.001225856,0.00007772217,0.00006317327,0.0002387363,0.0163409,0.0001819114,0.001249668,0.01648826],"study_design_scores_gemma":[0.8950467,0.1023309,0.0008899206,0.00003433412,0.000283084,0.00002544075,0.00001357109,0.0001803754,0.0005941932,0.00008192943,0.0005072312,0.00001223698],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9483319,0.007566391,0.003634336,0.00168892,0.001614558,0.03227417,0.002466077,0.0004263752,0.001997226],"genre_scores_gemma":[0.9324552,0.00555908,0.009702002,0.003481324,0.001347446,0.0408486,0.001991135,0.00006264316,0.004552565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006414789,"threshold_uncertainty_score":0.02145964,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06484357411088452,"score_gpt":0.4080139338656373,"score_spread":0.3431703597547528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}